For example, vascular endothelial growth factor (VEGF) or its receptor have been popular targets for siRNA to counteract overt angiogenesis present in diabetic macular edema, age-related macular degeneration, and cancerous solid tumors [2]. The gene discussed is VEGFA; the disease is diabetic macular edema.